Geoffroy Vellieux1,2*
Romain Sonneville3,4Sérafima Vledouts1,2
Pierre Jaquet3,4Anny Rouvel-Tallec1,2Marie-Pia d’Ortho1,2- 1Université de Paris, NeuroDiderot, Inserm, Paris, France
- 2Neurophysiologie clinique, Service de Physiologie – Explorations Fonctionnelles, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France
- 3Médecine Intensive-Réanimation, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France
- 4Université de Paris, UMR 1148, LVTS, Paris, France
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide since the end of year 2019 and is currently responsive for coronavirus infectious disease 2019 (COVID-19). The first reports considered COVID-19 as a respiratory tract disease responsible for pneumonia, but numerous studies rapidly emerged to warn the medical community of COVID-19-associated neurological manifestations, including encephalopathy at the acute phase and other postinfectious manifestations. Using standard visual analysis or spectral analysis, recent studies reported electroencephalographic (EEG) findings of COVID-19 patients with various neurological symptoms. Most EEG recordings were normal or revealed non-specific abnormalities, such as focal or generalized slowing, interictal epileptic figures, seizures, or status epilepticus. Interestingly, novel EEG abnormalities over frontal areas were also described at the acute phase. Underlying mechanisms leading to brain injury in COVID-19 are still unknown and matters of debate. These frontal EEG abnormalities could emphasize the hypothesis whereby SARS-CoV-2 enters the central nervous system (CNS) through olfactory structures and then spreads in CNS via frontal lobes. This hypothesis is reinforced by the presence of anosmia in a significant proportion of COVID-19 patients and by neuroimaging studies confirming orbitofrontal abnormalities. COVID-19 represents a new viral disease characterized by not only respiratory symptoms but also a systemic invasion associated with extra-respiratory signs. Neurological symptoms must be the focus of our attention, and functional brain evaluation with EEG is crucial, in combination with anatomical and functional brain imaging, to better understand its pathophysiology. Evolution of symptoms together with EEG patterns at the distance of the acute episode should also be scrutinized.
Introduction
The coronavirus infectious disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, was initially recognized as a respiratory tract disease which could lead to an acute respiratory distress syndrome. However, there is growing evidence of a multi-organ involvement (Gupta et al., 2020). Several authors reported central nervous system (CNS) manifestations, as anosmia referring to olfactory tract involvement. Other critical presentations, including meningoencephalitis, seizures, status epilepticus (SE), encephalopathy, and altered mental status were also described (Ellul et al., 2020). Neurological complications, such as encephalopathy and seizures/SE, and electroencephalographic (EEG) abnormalities, mainly diffuse slowing and epileptiform discharges, have already been described in past viral pandemics such as influenza A H1N1 (Ekstrand et al., 2010; Kedia et al., 2011; Ibrahim and Haddad, 2014). Results of EEG in patients with COVID-19 were increasingly reported. While the volume of COVID-19-related case studies is still growing, we present the spectrum of EEG findings published at the moment, allowing physicians to be cognizant of this new and emerging literature while dealing with COVID-19 patients.
Methods
We considered all studies with EEG findings at the acute phase in COVID-19 patients with neurological manifestations. We performed an electronic research from December 1, 2019, to October 1, 2020, using the database PUBMED by Medline with the following terms (in all fields): (i) (“EEG” OR “electroencephalogram” OR “electroencephalography”) AND (“COVID” OR “coronavirus” OR “SARS-CoV-2”) and (ii) (“brain” OR “nervous system” OR “neurology”) AND (“COVID” OR “coronavirus” OR “SARS-CoV-2”). We also scanned the reference lists of all included articles or relevant reviews for studies to be included in our work. We did not include reviews, non-English articles, unavailable full-text articles, and animal studies. After exclusion of duplicates, we screened the title/abstract or full-text reports and decided whether these met the inclusion criteria.
EEG Observations in COVID-19 Patients
A total of 107 studies were included. Normal EEG findings were reported in adult series (Cecchetti et al., 2020; Helms et al., 2020b; Petrescu et al., 2020) and case reports of patients who displayed various neurological conditions such as focal or generalized seizures (Elgamasy et al., 2020; Fasano et al., 2020; García-Howard et al., 2020; Lyons et al., 2020), non-epileptic seizures (Logmin et al., 2020), myoclonus (Muccioli et al., 2020b; Rábano-Suárez et al., 2020), psychotic symptoms (Lim et al., 2020), encephalopathy (Andriuta et al., 2020; Chaumont et al., 2020; Delorme et al., 2020; Paterson et al., 2020; Perrin et al., 2020), encephalitis (Paterson et al., 2020), brainstem encephalitis (Khoo et al., 2020), and encephalomyelitis (Zoghi et al., 2020). Some studies also reported non-specific abnormalities without more precise EEG features specified by authors (Chougar et al., 2020; Farley and Zuberi, 2020; Freij et al., 2020; Helms et al., 2020a; Pugin et al., 2020).
Diffuse and Focal Slowing
Diffuse slowing of the background activity or focal slowing (sometimes associated with focal sharp waves or epileptiform discharges) was the most frequently published abnormality, especially in adult series (Ayub et al., 2020; Canham et al., 2020; Cecchetti et al., 2020; Chougar et al., 2020; Galanopoulou et al., 2020; Helms et al., 2020a, b; Louis et al., 2020; Pasini et al., 2020; Pellinen et al., 2020; Petrescu et al., 2020; Pilotto et al., 2020a; Scullen et al., 2020; Sethi, 2020; Vespignani et al., 2020) (Figure 1A). Main results of adult series including at least 10 patients with confirmed SARS-CoV-2 infection and EEG recordings are summarized in Table 1. Diffuse or focal slowing was also associated in many case reports with various neurological presentations, mainly of vascular or inflammatory origin. Main vascular complications included ischemic and hemorrhagic strokes (Chaumont et al., 2020; Díaz-Pérez et al., 2020; Morassi et al., 2020; Soldatelli et al., 2020; Zahid et al., 2020), intracranial hemorrhage with cerebral venous thrombosis (Roy-Gash et al., 2020), posterior reversible encephalopathy syndrome (PRES) (Llansó and Urra, 2020; Princiotta Cariddi et al., 2020), intracranial vasculitis (Dixon et al., 2020), subarachnoid hemorrhage (Harrogate et al., 2020), acute hemorrhagic leukoencephalitis or leukoencephalomyelitis (Handa et al., 2020; Kihira et al., 2020; Svedung Wettervik et al., 2020), and acute necrotizing encephalopathy (Delamarre et al., 2020; Virhammar et al., 2020). Main inflammatory syndromes included acute disseminated encephalomyelitis (ADEM) (Parsons et al., 2020; Umapathi et al., 2020), acute leukoencephalopathy (Abenza-Abildúa et al., 2020; Anand et al., 2020; Brun et al., 2020; Huang H. et al., 2020; Kihira et al., 2020; Klironomos et al., 2020), acute leukoencephalitis (Perrin et al., 2020), meningoencephalitis without any acute lesions on brain imaging (Duong et al., 2020; El-Zein et al., 2020; Pilotto et al., 2020b), Bickerstaff encephalitis (Llorente Ayuso et al., 2020), and concomitant autoimmune encephalitis (Grimaldi et al., 2020; Panariello et al., 2020). In critically ill patients, other conditions were described including post-hypoxic injury (Fischer et al., 2020; Radmanesh et al., 2020; Radnis et al., 2020; Vellieux et al., 2020), unresponsiveness after sedation discontinuation (Espinosa et al., 2020; Vellieux et al., 2020), encephalopathy or altered mental status without any acute lesions on brain imaging (Chaumont et al., 2020; Delorme et al., 2020; Filatov et al., 2020; Gaughan et al., 2020; Jang et al., 2020; Manganelli et al., 2020; Muccioli et al., 2020a; Méndez-Guerrero et al., 2020; Romero-Sánchez et al., 2020; Shekhar et al., 2020), encephalopathy with seizures (Ashraf and Sajed, 2020; Benameur et al., 2020; Farhadian et al., 2020; Haddad et al., 2020), defined toxic/metabolic encephalopathy (Flamand et al., 2020; Radmard et al., 2020; Rasmussen et al., 2020), neuroleptic malignant syndrome (Kajani et al., 2020), after seizures or SE (Anand et al., 2020; Edén et al., 2020; Emami et al., 2020), and critical illness-associated cerebral microbleeds (De Stefano et al., 2020). EEG slowing was also observed in pediatric reports (Abdel-Mannan et al., 2020; Abel et al., 2020; Dugue et al., 2020; Panda et al., 2020).
Figure 1. EEG findings in COVID-19 patients. (A) Diffuse theta–delta slowing and continuous generalized periodic discharges, reproduced with authors’ agreement from Petrescu et al. (2020). (B) Emergence of low-amplitude ictal fast rhythmic activity over left frontocentral and midline regions (marked with an arrow), reproduced with authors’ agreement from Somani et al. (2020). (C) Continuous, periodic, monomorphic diphasic, delta slow waves over both frontal areas, published in Vellieux et al. (2020).
Table 1. Main results of case series including at least 10 patients admitted for COVID-19 with EEG recordings.
Seizures and SE
Seizures and/or SE were recorded in 10 patients out of 111 included in the series of Pellinen et al. (2020), in 2 out of 22 in the series of Louis et al. (2020), in 1 out of 37 in the series of Ayub et al. (2020), in 1 out of 15 in the series of Pasini et al. (2020), in 1 out of 27 in the series of Scullen et al. (2020), and in an unknown precise number of patients out of the 73 included in the series of Chougar et al. (2020) (Table 1).
Seizures and/or SE were recorded in reports of patients without any acute or chronic cortical lesions on brain imaging nor cerebrospinal fluid (CSF) abnormalities. The EEG of the patient reported by Balloy et al. (2020) revealed two widespread, but predominantly in frontal localizations, seizures that were interrupted by a moderate interictal frontal activity. Sohal and Mansur (2020) reported a patient whose 24-h EEG revealed six left temporal seizures and left temporal sharp waves. One of the two patients reported by Somani et al. (2020) displayed, on a continuous EEG (cEEG) monitoring, multiple seizures emanating from the midline and left frontocentral regions (Figure 1B). Hepburn et al. (2020) reported the cases of two patients whose cEEG monitoring showed, for the first one, three focal seizures arising from the right frontocentral region and, for the second one, left more than right frontotemporal seizures which progressed to focal SE. The EEG of the patient reported by Le Guennec et al. (2020) revealed a non-convulsive SE (NCSE) over the right frontal region. The brain MRI of this patient only showed peri-ictal diffusion abnormalities over the right orbital and mesial prefrontal cortex and right caudate nucleus. Flamand et al. (2020) reported the case of a patient who benefited from several EEG. The first two EEG findings were consistent with a bilateral frontal SE. One EEG in the series of five patients reported by Chen et al. (2020) showed a bifrontal SE, and another one revealed a generalized NCSE. Finally, the EEG of the patient reported by Rodrigo-Armenteros et al. (2020) showed a bilateral frontotemporal NCSE.
Seizures and/or SE were recorded more rarely in patients with acute CNS lesions on brain imaging and/or significant CSF abnormalities, of either vascular or inflammatory origin. Among the four patients with a PRES reported by Parauda et al. (2020), two had seizures or SE emanating from posterior regions: for the first one, a focal NCSE arising from the left posterior quadrant and, for the second one, focal seizures arising from the right posterior quadrant. The history of a 2-month-old boy was published by Schupper et al. (2020). His brain imaging revealed multiple infarctions with hemorrhagic transformations, and his cEEG showed NCSE. Zanin et al. (2020) published the case of a patient with diffuse CNS demyelinating lesions on brain and spine imaging whose EEG revealed two seizures starting from the right frontotemporal region and diffusing in the homologous contralateral hemisphere. Hussein et al. (2020) reported the case of a patient with an ADEM whose EEG revealed left hemispheric seizures and, 3 days later, brief focal right posterior seizures. Finally, Bernard-Valnet et al. (2020) reported the history of a patient with a lymphocytic meningitis on CSF analysis with normal brain MRI whose EEG showed a focal anterior NCSE.
Seizures and/or SE were recorded in patients with a prior neurological history and radiological sequelae but without any acute lesions. The EEG of the second patient, who had a prior history of skull base surgery, reported by Somani et al. (2020) showed recurrent seizures emanating from either right or left frontocentroparietal regions. Vollono et al. (2020) reported the case of a left frontocentrotemporal SE in a patient with a remote herpes simplex virus 1 encephalitis.
Seizures were reported on cEEG in the series of 33 patients published by Radmard et al. (2020), as frontotemporal and parasagittal seizures in two patients, but without precise imaging or CSF results available for these two patients.
Rhythmic and Periodic Discharges
Rhythmic discharges were mentioned in series, as generalized rhythmic delta activity (GRDA) (Ayub et al., 2020; Galanopoulou et al., 2020; Louis et al., 2020; Pellinen et al., 2020; Petrescu et al., 2020), lateralized rhythmic delta activity (LRDA) (Ayub et al., 2020; Galanopoulou et al., 2020; Louis et al., 2020; Pellinen et al., 2020), and frontal intermittent rhythmic delta activity (Canham et al., 2020; Pasini et al., 2020) (Table 1). Rhythmic patterns were also reported in a few case reports. Vandervorst et al. (2020) published the EEG of a patient with a clinical and radiological picture of encephalitis with temporal bilateral more left than right imaging abnormalities. The EEG showed short-lasting left temporal LRDA. In the series of Beach et al. (2020), one patient, with a previous history of dementia with Lewy bodies and remote traumatic brain injury, displayed GRDA with sharp contouring and bifrontal predominance, without any acute lesions on brain imaging. The EEG of the three other patients reported in the series of Chen et al. (2020) previously mentioned revealed GRDA, with unremarkable CSF analysis for the three and no acute lesions on brain imaging for one of them (unavailable for the two others). One EEG recorded among the seven patients reported by Anand et al. (2020) showed GRDA in a patient with extensive leukoencephalopathy on brain MRI and normal CSF sample.
Periodic discharges were noted in series, as generalized periodic discharges (GPDs) (Ayub et al., 2020; Galanopoulou et al., 2020; Louis et al., 2020; Pellinen et al., 2020; Petrescu et al., 2020; Vespignani et al., 2020) and lateralized periodic discharges (LPDs) (Pellinen et al., 2020; Petrescu et al., 2020; Vespignani et al., 2020) (Table 1). Especially, in the series of Vespignani et al. (2020), five EEGs out of 26 showed periodic discharges. Four of these five patients were under mechanical ventilation (MV), and three were sedated. One patient suffered from a cardiac arrest. EEG showed periodic (with a < 4 s interval), monomorphic biphasic, delta activity, which was diffuse with frontal predominance for four and lateralized over right frontal area for one. The second patient reported in the work of Beach al. previously mentioned presented with a left-sided acute-on-chronic subdural hematoma (SDH) due to a fall with head trauma. The EEG showed frequent runs of epileptiform GPDs (Beach et al., 2020). Young et al. (2020) reported 1–1.5 Hz LPDs and diffuse delta–theta slowing in a patient who displayed Creutzfeldt–Jakob disease in tandem with symptomatic onset of COVID-19. Conte et al. (2020) published the history of a patient who presented a severe COVID-19 pneumonia and then a PRES-like encephalopathy. She displayed focal seizures, and after seizure treatment, EEG revealed LPDs in the right posterior regions. Vellieux et al. (2020) published the EEG of two critically ill patients who displayed a severe COVID-19 pneumonia requiring MV. For the first one, the brain MRI was consistent with a hypoxic encephalopathy, and the EEG was recorded while he was sedated and under extracorporeal membrane oxygenation. For the second one, the EEG was recorded 24 h after sedation discontinuation. EEG revealed continuous, symmetric, non-reactive, generalized but mainly bifrontal, monomorphic diphasic or even triphasic, periodic (with a short interval of 1–2 s) delta slow waves (Figure 1C). One patient, without any acute abnormalities on brain MRI and with normal CSF analysis, reported by Delorme et al. (2020) showed GPDs. In the previously mentioned case reported by Le Guennec et al. (2020), a control follow-up EEG was recorded the day after the first EEG. It showed persistent right frontal LPDs with a short interval (0.7–1.2 s). The brain MRI performed 1 month later was normal. Finally, the previously mentioned patient reported by Flamand et al. (2020) who benefited from iterative EEG showed, on the last two recordings, a generalized periodic triphasic activity with short periods (1–1.5 s) over a worsened background activity, without concomitant metabolic disorders.
Spectral Analysis
Two studies reported quantitative analysis of EEG (qEEG) in COVID-19 patients. The study of Pastor et al. (2020) reported 20 patients with COVID-19 encephalopathy for whom standard visual analysis of EEG showed scarce abnormalities. However, compared to 31 infectious toxic encephalopathy patients and 21 post-cardiorespiratory arrest encephalopathy patients, some qEEG features were specific in COVID-19 patients, such as the distribution of EEG bands, the structure of Shannon’s spectral entropy, and the hemispheric connectivity. Finally, the study of Pati et al. (2020) showed that some qEEG markers, especially an increase in both the theta power and its temporal variance during EEG reactivity, can predict a good neurological outcome in 10 critically ill COVID-19 patients.
Discussion
The vast majority of these studies emphasized the absence of specificity of EEG abnormalities reported in COVID-19 patients, as generalized slowing of the background activity, focal slowing sometimes associated with sharp waves, seizures, SE, and predictable pattern of metabolic/toxic or postanoxic encephalopathy in ICU patients. Numerous EEGs in the context of COVID-19 were recorded in elderly patients and mainly in male patients, with multiple comorbidities especially chronic brain disorders, under various psychotropic drugs or in critically ill conditions. Confounding factors such as infections, metabolic disturbances, severe hypoxemia, hyperthermia, and psychotropic drugs (such as antiepileptic or sedative drugs) were frequent at the time of EEG recordings. All these confounding factors may contribute to the modification of brain activity and therefore EEG findings. Thus, based on the current literature, it seems not possible to identify a specific EEG pattern due to the suspected neuroinvasion of SARS-CoV-2 in patients who displayed neurological manifestations of COVID-19.
Most current studies with available EEG data are case reports or retrospective single-center series. All reported patients are very heterogeneous concerning prior neurological histories, illness severity, and use of psychotropic drugs. Moreover, some studies reported EEG recorded with limited montage and number of electrodes that may limit the detection of EEG abnormalities. EEG is not a systematic exam in the diagnostic workup of COVID-19 patients. All patients reported in the current literature had an EEG for an urgent clinical indication due to concerning neurological symptoms. A wider neurological multimodality screening, including EEG, of COVID-19 patients may be suggested to grow the body of knowledge on the SARS-CoV-2 infection. However, it will face many logistic difficulties and ethical and safety concerns regarding the availability of trained personnel to EEG recordings and the risk of contamination with the SARS-CoV-2.
It should be pointed out that many EEG abnormalities reported were recorded over anterior or frontal regions. Regardless of EEG montage used by clinicians and neurophysiologists, it thus seems essential to include frontal electrodes. Periodicity, morphology, and reactivity of these frontal abnormalities were not mentioned in all studies. Moreover, a few reported periodic patterns, as GPDs (Ayub et al., 2020; Beach et al., 2020; Delorme et al., 2020; Louis et al., 2020; Pellinen et al., 2020; Petrescu et al., 2020), GPDs with bifrontal predominance (Galanopoulou et al., 2020; Vellieux et al., 2020; Vespignani et al., 2020), and LPDs (Conte et al., 2020; Le Guennec et al., 2020; Pellinen et al., 2020; Petrescu et al., 2020; Vespignani et al., 2020; Young et al., 2020). In particular, these frontal periodic discharges were monomorphic and displayed a short interval, and the absence of reactivity was noted (Vellieux et al., 2020; Vespignani et al., 2020). These frontal periodic discharges may indicate an acute neurological process linked to the brain SARS-CoV-2 infection. In COVID-19 patients, the combination of the frontal localization of these EEG discharges, the frequently reported anosmia (Yazdanpanah et al., 2020), the olfactory bulb abnormalities found on brain imaging (Lin et al., 2020), and the hypometabolism within the orbitofrontal cortex on functional brain imaging (Karimi-Galougahi et al., 2020) may support the hypothesis whereby SARS-CoV-2 could invade the brain through the olfactory pathway. Then, it could spread transneuronally to other related brain areas particularly to frontal lobes, especially the orbital prefrontal cortex, which are adjacent to olfactory structures (Huang J. et al., 2020).
Conclusion
In the context of the SARS-CoV-2 infection, increasing EEG results were published along with clinical reports describing various neurological symptoms in patients with COVID-19. Due to the suspected neuroinvasion of SARS-CoV-2, the major issue when interpreting EEG is to determine whether the observed abnormalities reflect this viral neuroinvasion, a severe encephalopathy with systemic and brain inflammation, hypoxemia and hyperthermia, and/or many confounding factors especially due to critical illness. At this time, no study had described specific EEG abnormalities of the SARS-CoV-2 infection. The majority of currently reported EEGs showed generalized slowing, focal slowing, epileptiform discharges with seizures, and SE. However, frontal discharges, for some periodic, may integrate in the olfactory hypothesis of the CNS invasion of SARS-CoV-2. It reinforces the need to accumulate precise neurophysiological observations of COVID-19 patients worldwide and to aggregate multimodality screening of these patients also with clinical, radiological, biological, and neuropathological data.
Author Contributions
GV collected the data and wrote the manuscript. RS, SV, PJ, and AR-T revised the manuscript. M-PO suggested and revised the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References
Abdel-Mannan, O., Eyre, M., Löbel, U., Bamford, A., Eltze, C., Hameed, B., et al. (2020). Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 77:e202687. doi: 10.1001/jamaneurol.2020.2687
Abel, D., Shen, M. Y., Abid, Z., Hennigan, C., Boneparth, A., Miller, E. H., et al. (2020). Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19. Neurology 95, 745–748. doi: 10.1212/WNL.0000000000010652
Abenza-Abildúa, M. J., Novo-Aparicio, S., Moreno-Zabaleta, R., Algarra-Lucas, M. C., Rojo Moreno-Arcones, B., and Salvador-Maya, M. Á, et al. (2020). Encephalopathy in severe SARS-CoV2 infection: inflammatory or infectious? Int. J. Infect. Dis. 98, 398–400. doi: 10.1016/j.ijid.2020.07.020
Anand, P., Al-Faraj, A., Sader, E., Dashkoff, J., Abdennadher, M., Murugesan, R., et al. (2020). Seizure as the presenting symptom of COVID-19: a retrospective case series. Epilepsy Behav. 112:107335. doi: 10.1016/j.yebeh.2020.107335
Andriuta, D., Roger, P.-A., Thibault, W., Toublanc, B., Sauzay, C., Castelain, S., et al. (2020). COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF. J. Neurol. 11, 1–2. doi: 10.1007/s00415-020-09975-1
Ashraf, M., and Sajed, S. (2020). Seizures related to coronavirus disease (COVID-19): case series and literature review. Cureus 12:e9378. doi: 10.7759/cureus.9378
Ayub, N., Cohen, J., Jing, J., Jain, A., Tesh, R., Mukerji, S. S., et al. (2020). Clinical electroencephalography findings and considerations in hospitalized patients with coronavirus SARS-CoV-2. medRxiv [Preprint]. doi: 10.1101/2020.07.13.20152207
Balloy, G., Leclair-Visonneau, L., Péréon, Y., Magot, A., Peyre, A., Mahé, P.-J., et al. (2020). Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin. Neurophysiol. 131, 2059–2061. doi: 10.1016/j.clinph.2020.05.005
Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., et al. (2020). Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen. Hosp. Psychiatry 65, 47–53. doi: 10.1016/j.genhosppsych.2020.05.008
Benameur, K., Agarwal, A., Auld, S. C., Butters, M. P., Webster, A. S., Ozturk, T., et al. (2020). Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020. Emerg. Infect. Dis. 26, 2016–2021. doi: 10.3201/eid2609.202122
Bernard-Valnet, R., Pizzarotti, B., Anichini, A., Demars, Y., Russo, E., Schmidhauser, M., et al. (2020). Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur. J. Neurol. doi: 10.1111/ene.14298 [Epub ahead of print].
Brun, G., Hak, J.-F., Coze, S., Kaphan, E., Carvelli, J., Girard, N., et al. (2020). COVID-19-White matter and globus pallidum lesions: demyelination or small-vessel vasculitis? Neurol. Neuroimmunol. Neuroinflamm. 7:e777. doi: 10.1212/NXI.0000000000000777
Canham, L. J. W., Staniaszek, L. E., Mortimer, A. M., Nouri, L. F., and Kane, N. M. (2020). Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: a case series. Clin Neurophysiol Pract. 5, 199–205. doi: 10.1016/j.cnp.2020.06.001
Cecchetti, G., Vabanesi, M., Chieffo, R., Fanelli, G., Minicucci, F., Agosta, F., et al. (2020). Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study. J. Neurol. doi: 10.1007/s00415-020-09958-2 [Epub ahead of print].
Chaumont, H., San-Galli, A., Martino, F., Couratier, C., Joguet, G., Carles, M., et al. (2020). Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. J. Neurol. 267, 3121–3127. doi: 10.1007/s00415-020-09986-y
Chen, W., Toprani, S., Werbaneth, K., and Falco-Walter, J. (2020). Status epilepticus and other EEG findings in patients with COVID-19: a case series. Seizure 81, 198–200. doi: 10.1016/j.seizure.2020.08.022
Chougar, L., Shor, N., Weiss, N., Galanaud, D., Leclercq, D., Mathon, B., et al. (2020). Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS-CoV-2 infection and neurological manifestations. Radiology 297:202422. doi: 10.1148/radiol.2020202422
Conte, G., Avignone, S., Carbonara, M., Meneri, M., Ortolano, F., Cinnante, C., et al. (2020). COVID-19-associated PRES-like encephalopathy with perivascular gadolinium enhancement. AJNR Am. J. Neuroradiol. 41, 2206–2208. doi: 10.3174/ajnr.A6762
De Stefano, P., Nencha, U., De Stefano, L., Mégevand, P., and Seeck, M. (2020). Focal EEG changes indicating critical illness associated cerebral microbleeds in a Covid-19 patient. Clin. Neurophysiol. Pract. 5, 125–129. doi: 10.1016/j.cnp.2020.05.004
Delamarre, L., Gollion, C., Grouteau, G., Rousset, D., Jimena, G., Roustan, J., et al. (2020). COVID-19–associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network. J. Neurol. Neurosurg. Psychiatry 91, 1004–1006. doi: 10.1136/jnnp-2020-323678
Delorme, C., Paccoud, O., Kas, A., Hesters, A., Bombois, S., Shambrook, P., et al. (2020). Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings. Eur. J. Neurol. 27, 2651–2657. doi: 10.1111/ene.14478
Díaz-Pérez, C., Ramos, C., López-Cruz, A., Muñoz Olmedo, J., Lázaro González, J., De Vega-Ríos, E., et al. (2020). Acutely altered mental status as the main clinical presentation of multiple strokes in critically ill patients with COVID-19. Neurol. Sci. 41, 2681–2684. doi: 10.1007/s10072-020-04679-w
Dixon, L., Coughlan, C., Karunaratne, K., Gorgoraptis, N., Varley, J., Husselbee, J., et al. (2020). Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2020-324291 [Epub ahead of print].
Dugue, R., Cay-Martínez, K. C., Thakur, K. T., Garcia, J. A., Chauhan, L. V., Williams, S. H., et al. (2020). Neurologic manifestations in an infant with COVID-19. Neurology 94, 1100–1102. doi: 10.1212/WNL.0000000000009653
Duong, L., Xu, P., and Liu, A. (2020). Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav. Immun. 87:33. doi: 10.1016/j.bbi.2020.04.024
Edén, A., Kanberg, N., Gostner, J., Fuchs, D., Hagberg, L., Andersson, L.-M., et al. (2020). CSF biomarkers in patients with COVID-19 and neurological symptoms: a case series. Neurology 96, e294–e300. doi: 10.1212/WNL.0000000000010977
Ekstrand, J. J., Herbener, A., Rawlings, J., Turney, B., Ampofo, K., Korgenski, E. K., et al. (2010). Heightened neurologic complications in children with pandemic H1N1 influenza. Ann. Neurol. 68, 762–766. doi: 10.1002/ana.22184
Elgamasy, S., Kamel, M. G., Ghozy, S., Khalil, A., Morra, M. E., and Islam, S. M. S. (2020). First case of focal epilepsy associated with SARS-coronavirus-2. J. Med. Virol. 92, 2238–2242. doi: 10.1002/jmv.26113
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., et al. (2020). Neurological associations of COVID-19. Lancet Neurol. 19, 767–783. doi: 10.1016/S1474-4422(20)30221-0
El-Zein, R. S., Cardinali, S., Murphy, C., and Keeling, T. (2020). COVID-19-associated meningoencephalitis treated with intravenous immunoglobulin. BMJ Case Rep. 13:e237364. doi: 10.1136/bcr-2020-237364
Emami, A., Fadakar, N., Akbari, A., Lotfi, M., Farazdaghi, M., Javanmardi, F., et al. (2020). Seizure in patients with COVID-19. Neurol. Sci. doi: 10.1007/s10072-020-04731-9 [Epub ahead of print].
Espinosa, P. S., Rizvi, Z., Sharma, P., Hindi, F., and Filatov, A. (2020). Neurological complications of coronavirus disease (COVID-19): encephalopathy, mri brain and cerebrospinal fluid findings: case 2. Cureus 12:e7930. doi: 10.7759/cureus.7930
Farhadian, S., Glick, L. R., Vogels, C. B. F., Thomas, J., Chiarella, J., Casanovas-Massana, A., et al. (2020). Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 20:248. doi: 10.1186/s12883-020-01812-2
Farley, M., and Zuberi, J. (2020). COVID-19 precipitating status epilepticus in a pediatric patient. Am. J. Case Rep. 21:e925776. doi: 10.12659/AJCR.925776
Fasano, A., Cavallieri, F., Canali, E., and Valzania, F. (2020). First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol. Sci. 41, 1651–1653. doi: 10.1007/s10072-020-04460-z
Filatov, A., Sharma, P., Hindi, F., and Espinosa, P. S. (2020). Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 12:e7352. doi: 10.7759/cureus.7352
Fischer, D., Threlkeld, Z. D., Bodien, Y. G., Kirsch, J. E., Huang, S. Y., Schaefer, P. W., et al. (2020). Intact brain network function in an unresponsive patient with COVID -19. Ann. Neurol. 88, 851–854.
Flamand, M., Perron, A., Buron, Y., and Szurhaj, W. (2020). Pay more attention to EEG in COVID-19 pandemic. Clin. Neurophysiol. 131, 2062–2064. doi: 10.1016/j.clinph.2020.05.011
Freij, B. J., Gebara, B. M., Tariq, R., Wang, A.-M., Gibson, J., El-Wiher, N., et al. (2020). Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child. BMC Pediatr. 20:429. doi: 10.1186/s12887-020-02308-1
Galanopoulou, A. S., Ferastraoaru, V., Correa, D. J., Cherian, K., Duberstein, S., Gursky, J., et al. (2020). EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: a small case series preliminary report. Epilepsia Open 5, 314–324. doi: 10.1002/epi4.12399
García-Howard, M., Herranz-Aguirre, M., Moreno-Galarraga, L., Urretavizcaya-Martínez, M., Alegría-Echauri, J., Gorría-Redondo, N., et al. (2020). Case report: benign infantile seizures temporally associated with COVID-19. Front. Pediatr. 8:507. doi: 10.3389/fped.2020.00507
Gaughan, M., Connolly, S., Direkze, S., and Kinsella, J. A. (2020). Acute new-onset symptomatic seizures in the context of mild COVID-19 infection. J. Neurol. doi: 10.1007/s00415-020-10214-w [Epub ahead of print].
Grimaldi, S., Lagarde, S., Harle, J.-R., Boucraut, J., and Guedj, E. (2020). Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies. J. Nucl. Med. 61, 1726–1729. doi: 10.2967/jnumed.120.249292
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., et al. (2020). Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017–1032. doi: 10.1038/s41591-020-0968-3
Haddad, S., Tayyar, R., Risch, L., Churchill, G., Fares, E., Choe, M., et al. (2020). Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient. IDCases 21:e00814. doi: 10.1016/j.idcr.2020.e00814
Handa, R., Nanda, S., Prasad, A., Anand, R., Zutshi, D., Dass, S. K., et al. (2020). Covid-19-associated acute haemorrhagic leukoencephalomyelitis. Neurol. Sci. doi: 10.1007/s10072-020-04703-z [Epub ahead of print].
Harrogate, S., Mortimer, A., Burrows, L., Fiddes, B., Thomas, I., and Rice, C. M. (2020). Non-aneurysmal subarachnoid haemorrhage in COVID-19. Neuroradiology doi: 10.1007/s00234-020-02535-4 [Epub ahead of print].
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., et al. (2020a). Neurologic Features in Severe SARS-CoV-2 Infection. N. Engl. J. Med. 382, 2268–2270. doi: 10.1056/NEJMc2008597
Helms, J., Kremer, S., Merdji, H., Schenck, M., Severac, F., Clere-Jehl, R., et al. (2020b). Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit. Care 24:491. doi: 10.1186/s13054-020-03200-1
Hepburn, M., Mullaguri, N., George, P., Hantus, S., Punia, V., Bhimraj, A., et al. (2020). Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit. Care doi: 10.1007/s12028-020-01006-1 [Epub ahead of print].
Huang, H., Eichelberger, H., Chan, M., Valdes, E., Kister, I., Krupp, L., et al. (2020). Pearls and Oy-sters: leukoencephalopathy in critically ill COVID-19 patients. Neurology 95, 753–757. doi: 10.1212/WNL.0000000000010636
Huang, J., Zheng, M., Tang, X., Chen, Y., Tong, A., and Zhou, L. (2020). Potential of SARS-CoV-2 to cause CNS infection: biologic fundamental and clinical experience. Front. Neurol. 11:659. doi: 10.3389/fneur.2020.00659
Hussein, O., Abd Elazim, A., and Torbey, M. T. (2020). Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM). J. Neuroimmunol. 349:577405. doi: 10.1016/j.jneuroim.2020.577405
Ibrahim, F., and Haddad, N. (2014). New onset refractory status epilepticus in a young man with H1N1 infection. Case Rep. Neurol. Med. 2014:585428. doi: 10.1155/2014/585428
Jang, K., Khatri, A., and Majure, D. T. (2020). COVID-19 leading to acute encephalopathy in a patient with heart transplant. J. Heart Lung Transplant. 39, 853–855. doi: 10.1016/j.healun.2020.05.016
Kajani, R., Apramian, A., Vega, A., Ubhayakar, N., Xu, P., and Liu, A. (2020). Neuroleptic malignant syndrome in a COVID-19 patient. Brain Behav. Immun. 88, 28–29. doi: 10.1016/j.bbi.2020.05.042
Karimi-Galougahi, M., Yousefi-Koma, A., Bakhshayeshkaram, M., Raad, N., and Haseli, S. (2020). 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad. Radiol. 27, 1042–1043. doi: 10.1016/j.acra.2020.04.030
Kedia, S., Stroud, B., Parsons, J., Schreiner, T., Curtis, D. J., Bagdure, D., et al. (2011). Pediatric neurological complications of 2009 pandemic influenza A (H1N1). Arch. Neurol. 68, 455–462. doi: 10.1001/archneurol.2010.318
Khoo, A., McLoughlin, B., Cheema, S., Weil, R. S., Lambert, C., Manji, H., et al. (2020). Postinfectious brainstem encephalitis associated with SARS-CoV-2. J. Neurol. Neurosurg. Psychiatry 91, 1013–1014. doi: 10.1136/jnnp-2020-323816
Kihira, S., Delman, B. N., Belani, P., Stein, L., Aggarwal, A., Rigney, B., et al. (2020). Imaging features of acute encephalopathy in patients with COVID-19: a case series. AJNR Am J Neuroradiol. 41, 1804–1808. doi: 10.3174/ajnr.A6715
Klironomos, S., Tzortzakakis, A., Kits, A., Öhberg, C., Kollia, E., Ahoromazdae, A., et al. (2020). Nervous System Involvement in COVID-19: results from a retrospective consecutive neuroimaging cohort. Radiology 297:202791. doi: 10.1148/radiol.2020202791
Le Guennec, L., Devianne, J., Jalin, L., Cao, A., Galanaud, D., Navarro, V., et al. (2020). Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia 61, e90–e94. doi: 10.1111/epi.16612
Lim, S. T., Janaway, B., Costello, H., Trip, A., and Price, G. (2020). Persistent psychotic symptoms following COVID-19 infection. BJPsych Open 6:e105. doi: 10.1192/bjo.2020.76
Lin, E., Lantos, J. E., Strauss, S. B., Phillips, C. D., Campion, T. R., Navi, B. B., et al. (2020). Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City. AJNR Am. J. Neuroradiol. 41, 2001–2008. doi: 10.3174/ajnr.A6793
Llansó, L., and Urra, X. (2020). Posterior reversible encephalopathy syndrome in COVID-19 disease: a case-report. SN Compr. Clin. Med. doi: 10.1007/s42399-020-00470-2 [Epub ahead of print].
Llorente Ayuso, L., Torres Rubio, P., Beijinho do Rosário, R. F., Giganto Arroyo, M. L., and Sierra-Hidalgo, F. (2020). Bickerstaff encephalitis after COVID-19. J. Neurol. doi: 10.1007/s00415-020-10201-1 [Epub ahead of print].
Logmin, K., Karam, M., Schichel, T., Harmel, J., and Wojtecki, L. (2020). Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19. J. Neurol. 267, 2490–2491. doi: 10.1007/s00415-020-09904-2
Louis, S., Dhawan, A., Newey, C., Nair, D., Jehi, L., Hantus, S., et al. (2020). Continuous electroencephalography characteristics and acute symptomatic seizures in COVID-19 patients. Clin. Neurophysiol. 131, 2651–2656. doi: 10.1016/j.clinph.2020.08.003
Lyons, S., O’Kelly, B., Woods, S., Rowan, C., Brady, D., Sheehan, G., et al. (2020). Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure 80, 113–114. doi: 10.1016/j.seizure.2020.06.010
Manganelli, F., Vargas, M., Iovino, A., Iacovazzo, C., Santoro, L., and Servillo, G. (2020). Brainstem involvement and respiratory failure in COVID-19. Neurol. Sci. 41, 1663–1665. doi: 10.1007/s10072-020-04487-2
Méndez-Guerrero, A., Laespada-García, M. I., Gómez-Grande, A., Ruiz-Ortiz, M., Blanco-Palmero, V. A., Azcarate-Diaz, F. J., et al. (2020). Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 95, e2109–e2118. doi: 10.1212/WNL.0000000000010282
Morassi, M., Bagatto, D., Cobelli, M., D’Agostini, S., Gigli, G. L., Bnà, C., et al. (2020). Stroke in patients with SARS-CoV-2 infection: case series. J. Neurol. 267, 2185–2192. doi: 10.1007/s00415-020-09885-2
Muccioli, L., Pensato, U., Cani, I., Guerra, L., Provini, F., Bordin, G., et al. (2020a). COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment. J. Neuroimmunol. 349:577400. doi: 10.1016/j.jneuroim.2020.577400
Muccioli, L., Rondelli, F., Ferri, L., Rossini, G., Cortelli, P., and Guarino, M. (2020b). Subcortical myoclonus in COVID-19: comprehensive evaluation of a patient. Mov. Disord. Clin. Pract. 7, 971–973. doi: 10.1002/mdc3.13046
Panariello, A., Bassetti, R., Radice, A., Rossotti, R., Puoti, M., Corradin, M., et al. (2020). Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav. Immun. 87, 179–181. doi: 10.1016/j.bbi.2020.05.054
Panda, P. K., Sharawat, I. K., Panda, P., Natarajan, V., Bhakat, R., and Dawman, L. (2020). Neurological Complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis. J. Trop. Pediatr. doi: 10.1093/tropej/fmaa070 [Epub ahead of print].
Parauda, S. C., Gao, V., Gewirtz, A. N., Parikh, N. S., Merkler, A. E., Lantos, J., et al. (2020). Posterior reversible encephalopathy syndrome in patients with COVID-19. J. Neurol. Sci. 416:117019. doi: 10.1016/j.jns.2020.117019
Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., and Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). J. Neurol. doi: 10.1007/s00415-020-09951-9 [Epub ahead of print].
Pasini, E., Bisulli, F., Volpi, L., Minardi, I., Tappatà, M., Muccioli, L., et al. (2020). EEG findings in COVID-19 related encephalopathy. Clin. Neurophysiol. 131, 2265–2267. doi: 10.1016/j.clinph.2020.07.003
Pastor, J., Vega-Zelaya, L., and Martín Abad, E. (2020). Specific EEG encephalopathy pattern in SARS-CoV-2 patients. J. Clin. Med. 9:1545. doi: 10.3390/jcm9051545
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., et al. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143, 3104–3120. doi: 10.1093/brain/awaa240
Pati, S., Toth, E., and Chaitanya, G. (2020). Quantitative EEG markers to prognosticate critically ill patients with COVID-19: a retrospective cohort study. Clin. Neurophysiol. 131, 1824–1826. doi: 10.1016/j.clinph.2020.06.001
Pellinen, J., Carroll, E., Friedman, D., Boffa, M., Dugan, P., Friedman, D. E., et al. (2020). Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia 61, 2097–2105. doi: 10.1111/epi.16667
Perrin, P., Collongues, N., Baloglu, S., Bedo, D., Bassand, X., Lavaux, T., et al. (2020). Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur. J. Neurol. 28, 248–258. doi: 10.1111/ene.14491
Petrescu, A.-M., Taussig, D., and Bouilleret, V. (2020). Electroencephalogram (EEG) in COVID-19: a systematic retrospective study. Neurophysiol. Clin. 50, 155–165. doi: 10.1016/j.neucli.2020.06.001
Pilotto, A., Masciocchi, S., Volonghi, I., Crabbio, M., Magni, E., De Giuli, V., et al. (2020a). Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study. J. Infect. Dis. 28:jiaa609. doi: 10.1093/infdis/jiaa609
Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020b). Steroid-responsive encephalitis in coronavirus disease 2019. Ann. Neurol. 88, 423–427. doi: 10.1002/ana.25783
Princiotta Cariddi, L., Tabaee Damavandi, P., Carimati, F., Banfi, P., Clemenzi, A., Marelli, M., et al. (2020). Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J. Neurol. doi: 10.1007/s00415-020-10001-7 [Epub ahead of print].
Pugin, D., Vargas, M.-I., Thieffry, C., Schibler, M., Grosgurin, O., Pugin, J., et al. (2020). COVID-19-related encephalopathy responsive to high doses glucocorticoids. Neurology 95, 543–546. doi: 10.1212/WNL.0000000000010354
Rábano-Suárez, P., Bermejo-Guerrero, L., Méndez-Guerrero, A., Parra-Serrano, J., Toledo-Alfocea, D., Sánchez-Tejerina, D., et al. (2020). Generalized myoclonus in COVID-19. Neurology 95, e767–e772. doi: 10.1212/WNL.0000000000009829
Radmanesh, A., Derman, A., and Ishida, K. (2020). COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy. J. Neurol. Sci. 415:116945. doi: 10.1016/j.jns.2020.116945
Radmard, S., Epstein, S. E., Roeder, H. J., Michalak, A. J., Shapiro, S. D., Boehme, A., et al. (2020). Inpatient neurology consultations during the onset of the SARS-CoV-2 New York city pandemic: a single center case series. Front. Neurol. 11:805. doi: 10.3389/fneur.2020.00805
Radnis, C., Qiu, S., Jhaveri, M., Da Silva, I., Szewka, A., and Koffman, L. (2020). Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia. J. Neurol. Sci. 418:117119. doi: 10.1016/j.jns.2020.117119
Rasmussen, C., Niculescu, I., Patel, S., and Krishnan, A. (2020). COVID-19 and involvement of the corpus callosum: potential effect of the cytokine storm? AJNR Am. J. Neuroradiol. 41, 1625–1628. doi: 10.3174/ajnr.A6680
Rodrigo-Armenteros, P., Uterga-Valiente, J. M., Zabala-Del-Arco, J., Taramundi-Argüeso, S., Erburu-Iriarte, M., Antón-Méndez, L., et al. (2020). Non-convulsive status epilepticus in a patient with COVID-19 infection. Clin. Neurophysiol. 131, 2588–2590. doi: 10.1016/j.clinph.2020.08.005
Romero-Sánchez, C. M., Díaz-Maroto, I., Fernández-Díaz, E., Sánchez-Larsen, Á, Layos-Romero, A., García-García, J., et al. (2020). Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95, e1060–e1070. doi: 10.1212/WNL.0000000000009937
Roy-Gash, F., De Mesmay, M., Devys, J.-M., Vespignani, H., Blanc, R., and Engrand, N. (2020). COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. Crit. Care 24:419. doi: 10.1186/s13054-020-03131-x
Schupper, A. J., Yaeger, K. A., and Morgenstern, P. F. (2020). Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Childs Nerv. Syst. 36, 1579–1580. doi: 10.1007/s00381-020-04755-8
Scullen, T., Keen, J., Mathkour, M., Dumont, A. S., and Kahn, L. (2020). Coronavirus 2019 (COVID-19)-associated encephalopathies and cerebrovascular disease: the new orleans experience. World Neurosurg. 141, e437–e446. doi: 10.1016/j.wneu.2020.05.192
Sethi, N. K. (2020). EEG during the COVID-19 pandemic: what remains the same and what is different. Clin. Neurophysiol. 131:1462. doi: 10.1016/j.clinph.2020.04.007
Shekhar, R., Sheikh, A. B., Suriya, S. S., Upadhyay, S., and Zafar, A. (2020). Neurological complications among native americans with COVID-19: our experience at a tertiary care academic hospital in the U.S. J. Stroke Cerebrovasc. Dis. 29:105260. doi: 10.1016/j.jstrokecerebrovasdis.2020.105260
Sohal, S., and Mansur, M. (2020). COVID-19 Presenting with Seizures. IDCases 20:e00782. doi: 10.1016/j.idcr.2020.e00782
Soldatelli, M. D., do Amaral, L. F., Veiga, V. C., Rojas, S. S. O., Omar, S., and Marussi, V. H. R. (2020). Neurovascular and perfusion imaging findings in coronavirus disease 2019: case report and literature review. Neuroradiol. J. 33, 368–373. doi: 10.1177/1971400920941652
Somani, S., Pati, S., Gaston, T., Chitlangia, A., and Agnihotri, S. (2020). De novo status epilepticus in patients with COVID-19. Ann. Clin. Trans. Neurol. 7, 1240–1244. doi: 10.1002/acn3.51071
Svedung Wettervik, T., Kumlien, E., Rostami, E., Howells, T., von Seth, M., Velickaite, V., et al. (2020). Intracranial pressure dynamics and cerebral vasomotor reactivity in coronavirus disease 2019 patient with acute encephalitis. Crit. Care Explor. 2:e0197. doi: 10.1097/CCE.0000000000000197
Umapathi, T., Jason, Q. W. M., Min, Y. J., Wai, K. H. S., Yuan, M. Y., Yee, J. C. C., et al. (2020). Encephalopathy in COVID-19 patients; viral, parainfectious, or both? eNeurologicalSci 21:100275. doi: 10.1016/j.ensci.2020.100275
Vandervorst, F., Guldolf, K., Peeters, I., Vanderhasselt, T., Michiels, K., Berends, K. J., et al. (2020). Encephalitis associated with the SARS-CoV-2 virus: a case report. Interdiscip. Neurosurg. 22:100821. doi: 10.1016/j.inat.2020.100821
Vellieux, G., Rouvel-Tallec, A., Jaquet, P., Grinea, A., Sonneville, R., and d’Ortho, M.-P. (2020). COVID-19 associated encephalopathy: is there a specific EEG pattern? Clin. Neurophysiol. 131, 1928–1930. doi: 10.1016/j.clinph.2020.06.005
Vespignani, H., Colas, D., Lavin, B. S., Soufflet, C., Maillard, L., Pourcher, V., et al. (2020). Report on electroencephalographic findings in critically ill patients with COVID -19. Ann. Neurol. 88, 626–630. doi: 10.1002/ana.25814
Virhammar, J., Kumlien, E., Fällmar, D., Frithiof, R., Jackmann, S., Sköld, M. K., et al. (2020). Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 95, 445–449. doi: 10.1212/WNL.0000000000010250
Vollono, C., Rollo, E., Romozzi, M., Frisullo, G., Servidei, S., Borghetti, A., et al. (2020). Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 78, 109–112. doi: 10.1016/j.seizure.2020.04.009
Yazdanpanah, N., Saghazadeh, A., and Rezaei, N. (2020). Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev. Neurosci. doi: 10.1515/revneuro-2020-0039 [Epub ahead of print].
Young, M. J., O’Hare, M., Matiello, M., and Schmahmann, J. D. (2020). Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav. Immun. 89, 601–603. doi: 10.1016/j.bbi.2020.07.007
Zahid, M. J., Baig, A., Galvez-Jimenez, N., and Martinez, N. (2020). Hemorrhagic stroke in setting of severe COVID-19 infection requiring Extracorporeal Membrane Oxygenation (ECMO). J. Stroke Cerebrovasc. Dis. 29:105016. doi: 10.1016/j.jstrokecerebrovasdis.2020.105016
Zanin, L., Saraceno, G., Panciani, P. P., Renisi, G., Signorini, L., Migliorati, K., et al. (2020). SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 162, 1491–1494. doi: 10.1007/s00701-020-04374-x
Keywords: SARS-CoV-2, coronavirus, COVID-19, encephalopathy, neurophysiology, EEG
Citation: Vellieux G, Sonneville R, Vledouts S, Jaquet P, Rouvel-Tallec A and d’Ortho M-P (2021) COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature. Front. Physiol. 11:622466. doi: 10.3389/fphys.2020.622466
Received: 28 October 2020; Accepted: 29 December 2020;
Published: 19 February 2021.
Edited by:
Georges Leftheriotis, Université Côte d’Azur, FranceReviewed by:
Simona Mrakic-Sposta, Italian National Research Council, ItalyMarion Simonetta-Moreau, INSERM UMR 1214 ToNIC, France
Copyright © 2021 Vellieux, Sonneville, Vledouts, Jaquet, Rouvel-Tallec and d’Ortho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Geoffroy Vellieux, Z2VvZmZyb3kudmVsbGlldXhAYXBocC5mcg==; Z2VvZmZyb3l2ZWxsaWV1eEBob3RtYWlsLmNvbQ==